Sara Elloudi

Sara Elloudi

Auto-generated profile, based on publicly available information

Sara Elloudi

Dermatology Department, Hassan II University Hospital, Fez, Morocco

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2022 in Our Dermatology Online
Verified
Journal Article
Closed access
JKJihad Kassel
Jihad Kassel
HBHanane Baybay
Hanane Baybay
IHIbtissam El Harch
Ibtissam El Harch
ICImane Couissi
Imane Couissi
SESara Elloudi
Sara Elloudi
FMFatima Zahra Mernissi
Fatima Zahra Mernissi
Background: Bullous pemphigoid is a common autoimmune bullous disease that mainly affects the elderly. Mucosal involvement in bullous pemphigoid remains rare and is in the order of 10% to 30%. Our objective was to evaluate the prevalence of mucosal involvement in our patients with bullous pemphigoid and to study its epidemiological, clinical, and therapeutic particularities. Material and Methods: We conducted a prospective epidemiological study, collecting patients with bullous pemphigoid, over a period of eleven years. We divided our study population into two groups, with and without mucosal damage, and compared different parameters between these two groups. Results: We collected 85 patients diagnosed with bullous pemphigoid. The mean age at diagnosis was 70.54 years. A neurological history was reported in nine (10.7%) of our patients, Drug intake was noted in 14.3%. Associations with autoimmune diseases were found in 25 patients. The typical form of PB was found in 74% of our patients with extensive skin involvement of more than 30% of the body surface in 44.7% of the patients. Twenty-nine patients (34.1%) presented mucosal lesions. The oral mucosa was the most frequently affected surface. Among the patients with mucosal involvement, twenty-five (86.2%) had isolated mucosal surface involvement. In patients with oral involvement, the most frequent mucosal lesions were erosions of the soft palate and the inner face of the cheeks. The comparative analysis between the two groups revealed that patients with mucosal involvement were younger, with an average age of 69.5 years vs. 71.12 years, p = 0.54. We also noted that patients with mucosal involvement more frequently presented with heard skin disease (p = 0.01). Regarding therapeutic management, we noted a more frequent need for the addition of systemic treatment to topical corticosteroids as compared to other patients (p = 0.01). Conclusion: The involvement of the oral mucosa remains rare and is correlated with more severe and extensive involvement of the disease with the ineffectiveness of first-line treatment. Further studies are needed at the national level to better assess these characteristics in the Moroccan population.

2 January 2023 in Our Dermatology Online
Verified
Journal Article
Closed access
CJChaymae Jroundi
Chaymae Jroundi
HBHanane Baybay
Hanane Baybay
HBHajar El Bennaye
Hajar El Bennaye
ICImane Couissi
Imane Couissi
ZDZakia Douhi
Zakia Douhi
MRMouna Rimani
Mouna Rimani
Pruritic papular eruption (PPE) described in HIV is a skin disease often encountered in HIV-positive patients. It is most often a sign of severe immunodeficiency and is commonly reported in African, Southeast Asian, and Indian populations [1,2]. It affects both adult females and males and may also be seen in children. The elementary lesion is a discrete, firm, erythematous, urticarial, very itchy papule of the extremities, face, and trunk, sparing the palms and soles. Painful excoriations in the genital mucosa are sometimes described. The CD4+ lymphocyte count (CD4) is usually below 250 cells/mm3. Histopathology reveals a lymphohistiocytic, inflammatory, perivascular, and periannexal infiltrate with a variable number of eosinophils. According to the World Health Organization (WHO), it is recommended to all HIV patients with antiretroviral therapy (ART), regardless of the staging and the CD4 count [3]. However, an elective treatment for PPE has not yet been found. Regression has been noted in some cases after the initiation of antiretroviral therapy. UVB therapy seems to be the most successful method in cases not improving with antiretroviral therapy [4]. Herein, we report the case of a patient who presented with PPE revealing HIV.

3 January 2025 in Our Dermatology Online
Verified
Journal Article
Closed access
SCSouad Choukri
Souad Choukri
HBHanane Baybay
Hanane Baybay
NKNoura Kalmi
Noura Kalmi
SESara Elloudi
Sara Elloudi
MSMeryem Soughi
Meryem Soughi
FMFatima Zahra Mernissi
Fatima Zahra Mernissi
Quality of life of patients with melasma: Is there a correlation between the Melasma Area and Severity Index (MASI) and the Melasma Quality of Life Scale (MelasQoL)?

1 July 2024 in Our Dermatology Online
Verified
Journal Article
Closed access
SBSiham Boularbah
Siham Boularbah
HBHanane Baybay
Hanane Baybay
SOSabrina Oujdi
Sabrina Oujdi
ZDZakia Douhi
Zakia Douhi
MSMeryem Soughi
Meryem Soughi
FMFatima Zahra Mernissi
Fatima Zahra Mernissi
Background: Infantile hemangiomas (IH) are the most common vascular tumors of infancy. Nearly 4–10% of infants require systemic treatment due to uncontrolled endothelial cell proliferation. Oral propranolol has been approved for the treatment of IH. Herein, we present our experience about the safety and tolerance of this treatment. Materials and Methods: This was a fourteen-year, prospective study conducted between 2008 and 2022 by the dermatology and pediatrics departments of the Hassan II University Hospital Center, located in Fez, Morocco, involving 215 children with infantile hemangioma with an indication for treatment by oral propranolol. Results: After a median follow-up period of fourteen years, the mean age of onset was six months. We encountered a 19% rate of side effects. Therapy was interrupted due to the occurrence of bronchospasm in two cases. Four patients (2.5%) had episodes of bronchiolitis. Other side effects were digestive disorders in 3%, sleep disorders in 6 cases, and coldness of the extremities in 7 cases. Four patients (8.6%) had a volumetric rebound. However, we noted sequelae, such as residual telangiectasias (39% cases), anetodermal skin in 15%, and unsightly scars in 24%. Conclusion: Our data shows that propranolol was generally well tolerated by young infants. We found side effects to be mostly minor, transient, and manageable, except for two cases of bronchospasm, whose treatment was permanently discontinued. This may be explained by the late age of treatment onset, yet we noted sequelae, such as telangiectasias and anetodermal skin. Key words: Propranolol, Infantile hemangioma, Safety

20 March 2022 in Our Dermatology Online
Verified
Journal Article
Closed access
AOAida Oulehri
Aida Oulehri
HBHanane Baybay
Hanane Baybay
SESara Elloudi
Sara Elloudi
ZDZakia Douhi
Zakia Douhi
FMFatima Zahra Mernissi
Fatima Zahra Mernissi
HFHind El Fatemi
Hind El Fatemi
Mucous membrane pemphigoid (MMP), previously known as cicatricial pemphigoid, is the second most frequent autoimmune subepithelial blistering disorder after bullous pemphigoid (BP). MMP has a broad spectrum of both clinical and immunological features, mostly affecting the mucous membranes, mainly the oral and ocular mucosae, but around 30% of cases develop skin lesions, which heal leaving atrophic scars and milia. Herein, we report a patient with widespread vegetating cutaneous and oral plaques, oral erosions, scarring conjunctivitis, and extensive mucosal lesions, who met the immunologic and microscopic criteria of cicatricial pemphigoid vegetans (CPV). The vegetative form of MMP is a very rare entity and, to our knowledge, this is the fifth patient recorded in the global literature. We present the unusual case of a young male who developed CPV possibly caused by chronic and heavy cannabis use and who was treated effectively with rituximab.

3 January 2025 in Our Dermatology Online
Verified
Journal Article
Open access
GHGhita Sqalli Houssini
Ghita Sqalli Houssini
ZDZakia Douhi
Zakia Douhi
MSMeryem Soughi
Meryem Soughi
SESara Elloudi
Sara Elloudi
HBHanane Baybay
Hanane Baybay
FMFatima Zahra Mernissi
Fatima Zahra Mernissi
Severe cutaneous adverse drug reactions: A search for the culprit in a retrospective study of 107 patients